187.15
-4.20
(-2.19%)
At close: April 17 at 5:35:14 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
879,500
815,100
746,400
612,300
701,900
Investing Cash Flow
-296,100
-340,000
-2,722,700
-957,500
-465,200
Financing Cash Flow
-573,000
84,900
1,986,100
220,700
-77,700
End Cash Position
705,500
678,900
116,600
107,100
223,600
Capital Expenditure
-295,900
-339,800
-473,600
-430,600
-324,000
Issuance of Capital Stock
1,900
1,193,600
1,300
--
--
Issuance of Debt
17,300
17,300
2,649,200
566,800
74,200
Repayment of Debt
-341,900
-879,200
-326,400
-174,400
-79,700
Repurchase of Capital Stock
--
-1,900
--
--
--
Free Cash Flow
583,600
475,300
272,800
181,700
377,900
12/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SRT3.DE Sartorius Aktiengesellschaft
209.00
-2.34%
SRT.F Sartorius Aktiengesellschaft
172.00
-1.71%
STMN.SW Straumann Holding AG
96.92
+1.49%
SRT.DE Sartorius Aktiengesellschaft
172.60
-1.93%
RGEN Repligen Corporation
130.00
-1.59%
SARTF Sartorius Aktiengesellschaft
165.49
0.00%
SRT3.F Sartorius Aktiengesellschaft
210.30
-0.05%
WST West Pharmaceutical Services, Inc.
201.90
-3.46%
AVTR Avantor, Inc.
15.10
-0.98%
SRT.SG Sartorius AG
171.60
+1.66%